Cancer biomarkers market for TMB, MSI / MMR anb mbkjvd TILs is estimated to be worth USD 860 million in 2030, predicts Roots Analysis | #rootsanalysis # Research # Pharma # Biotech # Analysis # Report

Science and Technology

Cancer biomarkers market for TMB, MSI / MMR anb mbkjvd TILs is estimated to be worth USD 860 million in 2030, predict

Roots Analysis is pleased to announce the publication of its recent study, titled, “Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019–2030.”

The fragment-based drug discovery market is estimated to be worth around USD 1.6 billion by 2030, predicts Roots Analysis | #rootsanalysis # Research # Pharma # Biotech # Analysis # Report

Science and Technology

The fragment-based drug discovery market is estimated to be worth around USD 1.6 billion by 2030, predicts Roots Analysi

Roots Analysis is pleased to announce the publication of its recent study, titled, “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030

Over 230 cobots, having variable payload capacities and degrees of freedom, have already been deployed, or are being actively adopted across various industries, including the life sciences and pharmaceutical industry, claims Roots Analysis | #rootsanalysis # Research # Pharma # Biotech # Analysis # Report

Science and Technology

Over 230 cobots, having variable payload capacities and degrees of freedom, have already been deployed, or are being act

Collaborative robots or cobots allow companies to automate their processes, are easy to program and deploy, can increase productivity manifolds, and offer high returns on investment.

The non-invasive cancer diagnostics market is estimated to be worth around USD 20.1 billion by 2030, predicts Roots Analysis | #rootsanalysis # Research # Pharma # Biotech # Analysis # Report

Science and Technology

The non-invasive cancer diagnostics market is estimated to be worth around USD 20.1 billion by 2030, predicts Roots Anal

Roots Analysis is pleased to announce the publication of its recent study, titled, “Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes and Other Biomarkers.”

The targeted protein degradation enabling technologies market, featuring a healthy pipeline of novel therapeutics, is anticipated to be worth over USD 3.3 billion by 2030, predicts Roots Analysis | #rootsanalysis # Research # Pharma # Biotech # Analysis # Report

Science and Technology

The targeted protein degradation enabling technologies market, featuring a healthy pipeline of novel therapeutics, is an

Roots Analysis has announced the addition of “Targeted Protein Degradation Market, 2021-2030” report to its list of offerings.